1The importance of laminin at the blood-brain barrierSebok K.Halder，Arjun Sapkota，Richard MilnerReviews2557-2563
2Repair and regeneration of peripheral nerve injuries that ablate branch pointsJuliAnne E.Allgood，George D.Bittner，Jared S.BushmanReviews2564-2568
3Cytokines,synaptic plasticity and network dynamics:a matter of balanceLaura Bellingacci，Jacopo Canonichesi，Andrea Mancini，Lucilla Parnetti，Massimiliano Di FilippoReviews2569-2572
4Axonal growth inhibitors and their receptors in spinal cord injury:from biology to clinical translationSílvia Sousa Chambel，Célia Duarte CruzReviews2573-2581
5The role of natural flavonoids on neuroinflammation as a therapeutic target for Alzheimer's disease:a narrative reviewQian Zhang，Yaping YanReviews2582-2591
6Thinking outside the black box:are the brain endothelial cells the new main target in Alzheimer's disease?Enrique Estudillo，Adolfo López-Ornelas，Alejandro Rodríguez-Oviedo，Neptali Gutiérrez de la Cruz，Marco Antonio Vargas-Hernández，Adriana JiménezReviews2592-2598
7CDP-choline to promote remyelination in multiple sclerosis:the need for a clinical trialViktoria Gudi，Pawet Grieb，Ralf A.Linker，Thomas SkripuletzReviews2599-2605
8Saliva:a challenging human fluid to diagnose brain disorders with a focus on Alzheimer's diseaseChristine Zürcher，Christian HumpelReviews2606-2610
9Gut-microbiome-brain axis:the crosstalk between the vagus nerve,alpha-synuclein and the brain in Parkinson's diseaseJúlio César Claudino dos Santos，Leandro Freitas Oliveira，Felipe Micelli Noleto，Camilla Teixeira Pinheiro Gusm?o，Gerly Anne de Castro Brito，Glauce Socorro de Barros VianaReviews2611-2614
10Animal models of vascularized nerve grafts:a systematic reviewFrancesca Toia，Daniele Matta，Federico De Michele，Roberto Pirrello，Adriana CordovaReviews2615-2618
11Retinoprotective compounds,current efficacy,and future prospectiveRachele Marino，Rebecca Sappington，Marco FeligioniReviews2619-2622
12Potential role of Lycium barbarum polysaccharides in glaucoma management:evidence from preclinical in vivo studiesYamunadevi Lakshmanan，Francisca Siu Yin Wong，Kwok-Fai So，Henry Ho-Lung ChanReviews2623-2632
13Therapies for Tau-associated neurodegenerative disorders:targeting molecules,synapses,and cellsMiranda RobbinsReviews2633-2637
14Molecular chaperones in stroke-induced immunosuppressionHaoduo Qiao，Qing Xu，Yunfei Xu，Yao Zhao，Nina He，Jie Tang，Jie Zhao，Ying LiuReviews2638-2644
15Role of exercise in the brain:focus on oligodendrocytes and remyelinationGrazia Maugeri，Velia D'Agata，Giuseppe MusumeciPerspectives2645-2646
16GABAergic synaptic transmission and plasticity oscillate across sleep and wakeKunwei Wu，Wei LuPerspectives2647-2648
17Implications of Olig2 silencing in oligodendrocyte precursor cellsLi-Pao Fang，Xianshu BaiPerspectives2649-2650
18Focus on LPA signaling:a promising therapeutic target to foster regeneration in immune-mediated neuropathiesFabian Szepanowski，Mark StettnerPerspectives2651-2652
19The presence of functional blood vessels in the ischemic core provides a therapeutic target for stroke recoveryGary P.Morris，Brad A.SutherlandPerspectives2653-2654
20Unexpected role of complement component 8 gamma chain in the inflamed brainJong-Heon Kim，Kyoungho SukPerspectives2655-2656
